There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-99893
M.F.
C25H29D3N8O
M.W.
463.59
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
PHA-848125-d3
References
"Brasca, M.G., et. al.: J. Med. Chem., 52, 5152 (2009); Albanese, C., e. al.: Mol. Cancer Ther., 9, 2243 (2010)"
PHA-848125-d3 is labelled PHA-848125 (P294490) which is a cyclin dependent kinase (CDK) inhibitor. Oral PHA-848125 showed antitumor activity via dual targeting of cyclin-dependent kinase and tropomyosin receptor kinase families in human carcinoma cell and xenografted mouse model of carcinoma.
Hazard Compound
Refer MSDS for complete information.
Overview
PHA-848125-d3 is labelled PHA-848125 (P294490) which is a cyclin dependent kinase (CDK) inhibitor. Oral PHA-848125 showed antitumor activity via dual targeting of cyclin-dependent kinase and tropomyosin receptor kinase families in human carcinoma cell and xenografted mouse model of carcinoma.
![N2-(Deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-d3](https://structures.clearsynth.com/CS-T-94864.JPG)
![D-[13C5]Xylose](https://structures.clearsynth.com/CS-T-87613.PNG)